ArticleJournal of Crohn's & colitis2021

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry.

Manasi Agrawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.